HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rick F Thorne Selected Research

Oleic Acid (Oleate)

4/2016Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rick F Thorne Research Topics

Disease

26Neoplasms (Cancer)
01/2022 - 11/2005
17Melanoma (Melanoma, Malignant)
01/2021 - 10/2007
5Breast Neoplasms (Breast Cancer)
06/2022 - 11/2005
4Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 08/2009
3Carcinogenesis
01/2022 - 11/2019
3Neoplasm Metastasis (Metastasis)
01/2022 - 11/2005
2Starvation
01/2022 - 02/2011
2Squamous Cell Carcinoma of Head and Neck
11/2019 - 11/2019
2Adenocarcinoma
12/2018 - 01/2018
2Insulin Resistance
04/2016 - 05/2006
2Atherosclerosis
11/2010 - 03/2007
2Stomach Neoplasms (Stomach Cancer)
02/2009 - 02/2008
2AIDS-Related Complex (ARC)
08/2008 - 02/2008
1Hyperthermia
01/2022
1Triple Negative Breast Neoplasms
01/2022
1Lymphatic Metastasis
01/2022
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021
1Chromosome Aberrations (Chromosome Abnormalities)
01/2021
1Leukemia
01/2019
1Anaplastic Thyroid Carcinoma
01/2018
1Adenoma (Adenomas)
01/2018
1Hypoxia (Hypoxemia)
01/2018
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018
1Lung Neoplasms (Lung Cancer)
01/2018
1Thyroid Neoplasms (Thyroid Cancer)
01/2018
1Small Cell Carcinoma
01/2018
1Genomic Instability
01/2018
1Liver Diseases (Liver Disease)
04/2016
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2016
1Non-alcoholic Fatty Liver Disease
04/2016
1Pain (Aches)
02/2015
1Prostatic Neoplasms (Prostate Cancer)
12/2014

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
06/2022 - 02/2008
8Small Interfering RNA (siRNA)IBA
09/2020 - 02/2008
7Long Noncoding RNAIBA
01/2022 - 01/2018
7Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
12/2018 - 02/2008
6Phosphotransferases (Kinase)IBA
01/2022 - 10/2007
5Messenger RNA (mRNA)IBA
09/2020 - 10/2010
4Protein Isoforms (Isoforms)IBA
01/2022 - 10/2007
4MicroRNAs (MicroRNA)IBA
10/2020 - 09/2011
4Cadherins (E-Cadherin)IBA
02/2017 - 08/2011
3Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2014
3RNA (Ribonucleic Acid)IBA
10/2020 - 01/2014
3Nerve Growth Factor (NGF)IBA
01/2018 - 12/2014
3Phosphatidylinositols (Phosphatidylinositol)IBA
01/2013 - 05/2009
3Endoplasmic Reticulum Chaperone BiPIBA
10/2010 - 02/2009
3Docetaxel (Taxotere)FDA Link
05/2009 - 10/2007
3ThapsigarginIBA
08/2008 - 11/2007
2Pharmaceutical PreparationsIBA
01/2022 - 02/2008
2Deubiquitinating EnzymesIBA
01/2021 - 09/2020
2Oxygen (Dioxygen)IBA
10/2020 - 01/2018
2Oncogene Proteins (Oncogene Protein)IBA
10/2020 - 01/2018
2Biological ProductsIBA
09/2020 - 01/2013
2TNF-Related Apoptosis-Inducing LigandIBA
12/2018 - 10/2010
2Nerve Growth Factors (Neurotrophins)IBA
01/2018 - 01/2018
2sortilinIBA
01/2018 - 01/2018
2LigandsIBA
01/2018 - 11/2007
2LipidsIBA
04/2016 - 11/2010
2Blocking AntibodiesIBA
10/2015 - 12/2014
2Protein Kinase CIBA
08/2014 - 10/2007
2FurinIBA
04/2014 - 08/2011
2TunicamycinIBA
08/2008 - 02/2008
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2008 - 10/2007
1Formaldehyde (Formol)FDA Link
06/2022
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
06/2022
1GAP-43 Protein (GAP 43 Protein)IBA
06/2022
1ParaffinIBA
06/2022
1AntibodiesIBA
06/2022
1Doublecortin-Like KinasesIBA
01/2022
1Cytokine Receptor gp130IBA
01/2022
1Serine (L-Serine)FDA Link
01/2022
1Hormones (Hormone)IBA
01/2022
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1SincalideFDA Link
01/2022
1ProteomeIBA
01/2021
1Tyrosine Kinase InhibitorsIBA
01/2021
1Mechanistic Target of Rapamycin Complex 2IBA
01/2021
1Histone DemethylasesIBA
01/2021
1Tumor Biomarkers (Tumor Markers)IBA
01/2021
1Imatinib Mesylate (Gleevec)FDA Link
01/2021
1RNA Precursors (Precursor, mRNA)IBA
01/2021
1Basic Helix-Loop-Helix Transcription FactorsIBA
12/2020
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
10/2020
1fascinIBA
11/2019
1Competitive Endogenous RNAIBA
11/2019
1UMI-77IBA
12/2018
1tyrosine receptor (receptor, tyrosine)IBA
01/2018
1Protein Kinases (Protein Kinase)IBA
01/2018
1Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
01/2018
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2018
1VemurafenibIBA
09/2017
1Nuclear Respiratory Factor 1IBA
09/2017
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2016
1Simvastatin (Zocor)FDA LinkGeneric
04/2016
1Oleic Acid (Oleate)IBA
04/2016
1LipopolysaccharidesIBA
02/2015
1Macrophage Migration-Inhibitory FactorsIBA
08/2014
1Fluorouracil (Carac)FDA LinkGeneric
08/2014

Therapy/Procedure

7Therapeutics
01/2022 - 02/2008